Amgen Inc (AMGN)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 5,877,000 | 6,232,000 | 3,661,000 | 6,700,000 | 9,409,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $5,877,000K
= 0.00
The debt-to-equity ratio for Amgen Inc has remained consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has either no debt or very minimal debt in relation to its equity. A debt-to-equity ratio of 0.00 generally suggests that the company is primarily funded by equity, which can be perceived positively as it reflects a lower financial risk and potentially higher financial stability. However, it is also important to consider that having too low a debt-to-equity ratio may mean missed opportunities for leveraging debt for potential growth or tax advantages. Overall, a consistent debt-to-equity ratio of 0.00 may imply a conservative financial structure for Amgen Inc.
Peer comparison
Dec 31, 2024